Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
Treudler
Regina
R
Zouboulis
Christos C
CC
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002478:Cells, Cultured; D003875:Drug Eruptions / Q000209:etiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000473:pathology; D017809:Fatal Outcome; D000077156:Gefitinib; D006801:Humans; D008297:Male; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000209:etiology / Q000473:pathology
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib